Skrining Mamografi dan Mortalitas Kanker Payudara
DOI:
https://doi.org/10.55175/cdk.v51i12.1139Kata Kunci:
Kanker payudara, mamografi, skriningAbstrak
Kanker payudara merupakan kanker terbanyak di Indonesia dan menjadi salah satu penyumbang angka kematian terbesar akibat kanker. Sekitar 70% kanker payudara baru terdeteksi pada stadium lanjut yang membuat angka mortalitas menjadi makin tinggi. Beberapa tindakan telah diupayakan untuk mendeteksi kanker payudara lebih dini, di antaranya skrining mamografi. Mamografi adalah pencitraan sinar X untuk mendeteksi kelainan pada payudara. American College of Radiology merekomendasikan skrining kanker payudara pada wanita berisiko mulai dari usia 40 tahun. Meskipun demikian, apakah skrining mamografi dapat menurunkan mortalitas akibat kanker payudara masih menjadi perdebatan.
Unduhan
Referensi
Sari A. Skrining mamografi dan mortalitas kanker payudara. J MKMI. 2019;15(1):1-6. DOI: 10.30597/mkmi.v15i1.5501.
The Global Cancer Observatory (GLOBOCAN). Cancer data - Indonesia. International Agency for Research on Cancer [Internet]. 2020. Availablefrom: https://gco.iarc.who.int/media/globocan/factsheets/populations/360-indonesia-fact-sheet.pdf.
Reeves R, Kaufman T. Mammography [Internet]. 2023 [cited 2023 Nov 15]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559310/.
Monticciolo DL, Newell MS, Hendrick RE, Helvie MA, Moy L, Monsees B, et al. Breast cancer screening for average-risk women: Recommendations from the ACR commission on breast imaging. J Am Coll Radiol. 2017;14(9):1137-43. DOI: 10.1016/j.jacr.2017.06.001.
Gerami R, Joni S, Akhondi N, Etemadi A, Fosouli M, Eghbal AF, et al. A literature review on the imaging methods for breast cancer. Int J Physiol Pathophysiol Pharmacol. 2022;14(3): 171–6. PMID: 35891932.
Ginsburg O, Yip C, Brooks A, Cabanes A, Caleffi M, Yataco JA, et al. Breast cancer early detection: A phased approach to implementation. Cancer 2020;126(10):2379–93. DOI: 10.1002/cncr.32887.
Gunawan A. Pemilihan pemeriksaan imaging untuk skrining karsinoma mammae. Cermin Dunia Kedokteran 2021;48(6):347–9. DOI: 10.55175/cdk.v48i6.86.
Soekersi H, Azhar Y, Akbari K. Peran mammografi untuk skrining kanker payudara: Sebuah tinjauan pustaka. J Indon Med Assoc. 2002;72(3):144-50.
American Cancer Society. Breast cancer early detection and diagnosis [Internet]. 2022 [cited 2024 May 13]. Available from: https://www.cancer.org/content/dam/CRC/PDF/Public/8579.00.pdf.
Berg WA, Zhang Z, Lehrer D, Jong RA, Pisano ED, Barr RG, et al. Detection of breast cancer with addition of annual screening ultrasound or a singlescreening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307(13):1394-404. DOI: 10.1001/jama.2012.388.
Siu AL, US Preventive Services Task Force. Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2016;164(4):279-96. DOI: 10.7326/M15-2886.
Rojas K, Stuckey A. Breast cancer epidemiology and risk factors. Clin Obstet Gynecol. 2016;59(4):651-72. DOI: 10.1097/GRF.0000000000000239.
Kowalski AE. Mammograms and mortality: How has the evidence evolved? J Econ Perspect. 2021;35(2):119–40. DOI: 10.1257/jep.35.2.119.
Flemban AF. Overdiagnosis due to screening mammography for breast cancer among women aged 40 years and over: A systematic review and meta-analysis. J Pers Med. 2023;13(3):523. DOI: 10.3390/jpm13030523.
Liu J, Lei J, Ou Y, Zhao Y, Tuo X, Zhang B, et al. Mammography diagnosis of breast cancer screening through machine learning: A systematic review and meta-analysis. Clin Exp Med. 2023;23(6):2341-56. DOI: 10.1007/s10238-022-00895-0.
Dibden A, Offman J, Duffy S, Gabe R. Worldwide review and meta-analysis of cohort studies measuring the effect of mammography screening programmes on incidence-based breast cancer mortality. Cancers (Basel). 2020;12(4):976. DOI: 10.3390/cancers12040976.
Duffy S, Vulkan D, Cuckle H, Parmar D, Sheikh S, Smith R, et al. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): Final results of a randomised, controlled trial. Lancet Oncol. 2020;21(9):1165-72. DOI: 10.1016/S1470-2045(20)30398-3.
Maroni R, Massat R, Parmar D, Dibden A, Cuzick J, Sasieni P, et al. A case-control study to evaluate the impact of the breast screening programme on mortality in England. Br J Cancer 2021;124(4):736–43. DOI: 10.1038/s41416-020-01163-2.
Narod S, Sun P, Wall C, Baines C, Miller A. Impact of screening mammography on mortality from breast cancer before age 60 in women 40 to 49 years of age. Curr Oncol. 2014;21(5):217-21. DOI: 10.3747/co.21.2067.
Duffy S, Tabar L, Yen A, Dean P, Smith R, Jonsson H, et al. Beneficial effect of consecutive screening mammography examinations on mortality from breast cancer: A prospective study. Radiology. 2021;299(3):541–47. DOI: 10.1148/radiol.2021203935.
Mayor S. Mammography screening has little or no effect on breast cancer deaths, Swedish data indicate. BMJ. 2012;345:e4847. DOI: 10.1136/bmj.e4847.
Christiansen R, Autier P, Stovring H. Change in effectiveness of mammography screening with decreasing breast cancer mortality: A population-based study. Eur J Public Health 2022;32(4):630–5. DOI: 10.1093/eurpub/ckac047.
Kementerian Kesehatan RI. Peraturan Menteri Kesehatan Republik Indonesia Nomor 34 Tahun 2015 Tentang Penanggulangan Kanker Payudara dan Kanker Leher Rahim. Kemenkes RI [Internet]. 2015. Available from: http://hukor.kemkes.go.id/uploads/produk_hukum/PMK_No._34_ttg_Penanggulangan_Kanker_Payudara_dan_Leher_Rahim_.pdf.
Kementerian Kesehatan RI. Pedoman teknis pengendalian kanker payudara dan kanker leher rahim. Direktorat Pengendalian Penyakit Tidak Menular [Internet]. 2016. Available from: https://p2ptm.kemkes.go.id/dokumen-ptm/pedoman-teknis-pengendalian-kanker-payudara-kanker-leher-rahim.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2024 Catharina Endah Wulandari
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
